Home Top Movers The Rally Continued For Cassava Sciences (SAVA), Up 43% Pre-Market

The Rally Continued For Cassava Sciences (SAVA), Up 43% Pre-Market

The biotechnology company, Cassava Sciences Inc. (SAVA), a developer of drugs for nervous system disorders, has been seeing its stock price rising 43.83% in early trades floating at $126.50 (07:12 a.m. EST). The rise could be attributed to results announced by the company on Tuesday of an interim analysis from an open-label study of the company’s leading drug candidate simufilam for the treatment of Alzheimer’s disease.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.  

The focus of Cassava Sciences is to identify and establish innovations for chronic diseases that are neurodegenerative. Cassava Sciences has merged state-of-the-art technologies with new neurobiology discoveries over the last 10 years to establish innovative solutions for Alzheimer’s disease. A chronic brain condition that destroys memory and reasoning skills is Alzheimer’s disease.

Read More

The firm announced this week the findings of an interim review of simufilam, it’s a lead drug candidate for the treatment of Alzheimer’s disease, from an open-label trial. The cognitive abilities and activity ratings of patients have increased after six months of simufilam medication, without any health complications.

Six months of simufilam therapy increased cognitive scores by 1.6 points on ADAS-Cog11, a 10 percent mean increase from baseline to month 6, in a clinical trial sponsored by the National Institutes of Health and performed by Cassava Sciences. Simufilam also increased dementia-related behavior, such as depression, paranoia, and agitation, in these same patients by 1.3 points on the Neuropsychiatric Inventory, a mean increase of 29 percent from baseline to month 6.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.  

There are no medication treatments at present to stop Alzheimer’s disease, even less to change its course. Approximately 5.8 million people are currently diagnosed with Alzheimer’s disease in the United States alone, and approximately 487,000 people aged 65 or older encountered Alzheimer’s disease in 2019. In the years ahead, the number of people living with Alzheimer’s disease is projected to rise significantly, resulting in a rising financial and social strain.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Why Nano Dimension (NNDM) Leapt 7% In Aftermarket Trading On Friday?

After-hours trading on Friday saw Nano Dimension Corp (Nasdaq: NNDM) hit $7.97 a share rising 4.73%. The stock saw a decline of -2.31% to...

What Caused The Anchiano Therapeutics (ANCN) To Continue Rally After-Hours?

The clinical-stage biotech company Anchiano Therapeutics Ltd. (Nasdaq: ANCN) saw its stock rising 40.12% in after-hours trades on Friday. The price of the company’s...

Are The Financial Results Weighing On Senseonics (SENS) Stock In Premarket Today?

Shares of medical technology Senseonics Holdings, Inc. (NYSE American: SENS) has been declining -9.67% in pre-market session today falling to a price level of...

ReTo Eco-Solutions, Inc. (RETO) Stock Fell 6% In Pre-Market Trading

The provider of technology solutions around ecological environments ReTo Eco-Solutions, Inc. (NASDAQ: RETO) has been facing a drop in its stock price in pre-market...

Fulgent Genetics (FLGT) Stock Rocketed 34.46% In Extended Trading Following Strong Financial Results

Shares of the testing services and comprehensive testing solutions technology company Fulgent Genetics, Inc. (NASDAQ: FLGT) rocketed 34.46% in the after-hour trades on Thursday....

Why Nano Dimension (NNDM) Leapt 7% In Aftermarket Trading On Friday?

After-hours trading on Friday saw Nano Dimension Corp (Nasdaq: NNDM) hit $7.97 a share rising 4.73%. The stock saw a decline of -2.31% to...

After An Impressive 300% Rally, Why Did Second Sight Medical Products (EYES) Get Dropped After-Hours?

Shares of the implantable visual prosthetics company, Second Sight Medical Products, Inc. (NASDAQ: EYES) have seen a fall of -12.61% in after-hours trading on...

After-Hours Market: More Gains For Bionano Genomics (BNGO)

Bionano Genomics, Inc. (Nasdaq: BNGO) saw its stock price continue rising even after the ring of the bell on Friday. The company gained 7.13%...

Related News

What Gave GEVO Stock A 9% Boost In Aftermarket Trading On Friday?

Gevo, Inc. (NASDAQ: GEVO) shares risen by 9.46% on Friday in after-hours trading, rising the stock price to $7.64. The company saw its stock...

Adaptive Biotechnologies Corporation (ADPT) Leapt 18% In Extended Trading. Here’s Why?

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial-stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, has seen its share price surging 18.16% in extended trading to $49.90.

Evofem Biosciences (EVFM) – Stock Fell In Early Trades Today: Why?

Shares of the biopharmaceutical company Evofem Biosciences, Inc., (NASDAQ: EVFM) have been sinking in the early trades today. The stock was buoying at $2.205...

The Aqua Metals (AQMS) Stock Is An Pre-Market Upsurge of 13% For What Reason?

The metal recycling firm Aqua Metals, Inc. (NASDAQ: AQMS) is on an uptick today in premarket session. As of 09:08 a.m. EST, the stock...

This Is Why Waitr Holdings (WTRH) Stock Jumped 26% After-Hours

The on-demand food ordering and delivery firm Waitr Holdings Inc. (Nasdaq: WTRH) saw its stock price surging 26.09% in after-hours trades following news of the company stepping into the cannabis market.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.